ArticleHematology reports2024

Clinical Validation of the Somatic FANCD2 Mutation (c.2022-5C>T) as a Novel Molecular Biomarker for Early Disease Progression in Chronic Myeloid Leukemia: A Case-Control Study.

Nawaf Alanazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.